Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01100502 |
|---|---|
| Brief Title: | A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) |
| First Submitted : | April 6, 2010 |
| First Submitted that Met QC Criteria : | April 8, 2010 |
| First Posted : | April 9, 2010 (Estimate) |
| Results First Submitted : | July 31, 2015 |
| Results First Submitted that Met QC Criteria : | October 7, 2015 |
| Results First Posted : | November 11, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 22, 2021 |
| Last Update Posted : | May 14, 2021 |